慢性阻塞性肺病的GOLD和STAR肺功能分类稳定性的比较
I-Lin Tsai1, Chang Ting-Chia2, Tang-Hsiu Huang1
1Division of Chest Medicine, Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan.
BMJ open respiratory research
|May 16, 2025
概括
慢性阻塞性肺病 (COPD) 的STAR分类显示了比GOLD分类更多的变化随着时间的推移. 这表明需要仔细考虑其在治疗COPD患者中的使用.
科学领域:
- 肺部医学 肺部医学
- 呼吸系统健康 呼吸系统健康
- 临床诊断 临床诊断 临床诊断
背景情况:
- 慢性阻塞性肺病 (COPD) 的诊断依赖于螺旋计.
- 空气流阻塞因比率分级 (STAR) 分类是对COPD严重性进行分级的新系统.
- STAR与全球慢性阻塞性肺病倡议 (GOLD) 分类的长期稳定性尚不清楚.
研究的目的:
- 将STAR分类的长期稳定性与COPD患者的GOLD分类进行比较.
- 评估三年来STAR和GOLD分类之间的一致性和变化.
主要方法:
- 在台湾对622名COPD患者进行了回顾性队列研究.
- 使用基于螺旋计的GOLD和STAR系统进行分类的患者.
- 评估了3年来的分类稳定性,注意模式:没有变化,进展,不稳定,逆转.
主要成果:
- 在STAR分类中,不稳定性/逆转率 (42.1%) 比GOLD (31.0%) 高.
- 3年来分类之间相当一致,但STAR表现出更大的变化.
- 与GOLD相比,STAR在第二阶段具有更多的不稳定性/逆转,而在第四阶段则较少.
结论:
- 星级分类显示出比金级更大的不稳定性和逆转模式.
- 这些发现表明,在长期的COPD治疗中,需要仔细考虑使用STAR.
- 需要进一步的研究来澄清临床影响,并完善STAR分类的使用.
相关概念视频
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
COPD: Management Using Bronchodilators and Corticosteroids
170
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
170
Lung Capacity
48.9K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
48.9K
Pulmonary Function Tests
285
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
285


